Results 71 to 80 of about 1,480 (113)

Primary screening for increased fracture risk by the FRAX® questionnaire-uptake rates in relation to invitation method. [PDF]

Arch Osteoporos, 2019
Moberg LME, Nilsson PM, Holmberg AH, Samsioe G, Borgfeldt C.   +4 more
europepmc   +1 more source

Efficacy of teriparatide compared with risedronate on FRAX^®-defined major osteoporotic fractures: results of the VERO clinical trial. [PDF]

Osteoporos Int, 2020
Body JJ, Marin F, Kendler DL, Zerbini CAF, López-Romero P, Möricke R, Casado E, Fahrleitner-Pammer A, Stepan JJ, Lespessailles E, Minisola S, Geusens P.   +11 more
europepmc   +1 more source

Fractures in CKD predialysis: the role of bone biopsy, biomarkers, and FRAX®. [PDF]

J Bras Nefrol
Carvalho AB.
europepmc   +1 more source

Use of FRAX(®) in men. [PDF]

Joint Bone Spine, 2016
Harvey NC, McCloskey E, Kanis JA.
europepmc   +1 more source

Relationship between areal BMD, FRAX®, and femoral strength in community-dwelling older Asian adults. [PDF]

Arch Osteoporos
Jha D, Chandran M, Koller D, Cheong VS, Praveen AD, Baker A, Gupta P, Lamoureux EL, Pálsson H, Ferguson SJ, Helgason B.   +10 more
europepmc   +1 more source

Clarifying WHO's position on the FRAX® tool for fracture prediction. [PDF]

Bull World Health Organ, 2016
Ford N, Norris SL, Hill SR.
europepmc   +1 more source

FRAX® Fracture Risks Are Associated with Coronary Artery Calcification Score. [PDF]

Dis Markers, 2017
Chuang TL, Li YD, Hsiao FT, Chuang MH, Wang YF.   +4 more
europepmc   +1 more source

Fracture risk assessment in patients with ileal urinary diversion after radical cystectomy: a comprehensive evaluation integrating bone mineral density, trabecular bone score, and FRAX®. [PDF]

Arch Osteoporos
Domínguez A, Casado E, Muñoz-Rodríguez J, Prats J, Grubicy ML, Masip N, Piqué C, Centeno C, Bonfill T, Fuertes D, Serra-Aracil X.   +10 more
europepmc   +1 more source

Functional Status Enhances the FRAX^® Prediction of Fractures in Myasthenia Gravis: A 10-Year Cohort Study. [PDF]

J Clin Med
Konno S, Uchi T, Kihara H, Sugimoto H.
europepmc   +1 more source

Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX^® Tool Application. [PDF]

Healthcare (Basel)
Konno S, Uchi T, Kihara H, Sugimoto H.
europepmc   +1 more source